DD Support Board and Research Team

[surfkast]

Talari/Cox still file lies and the SEC does not care.

No mention of PCFP in filings, plus other ongoing lies.

Here are just two highlights.

Denver, CO, March 12, 2018 (GLOBE NEWSWIRE) --

FutureLand Corp. (OTC: FUTL), a leading provider of strategic real estate investment, grow facilities and material solutions to the medical and recreational global cannabis industry, announced today that Apotheca Biosciences was bought by Cannabis Leaf (PCFP) through a merger agreement. FutureLand Corp. has 20% interest in Apotheca Biosciences.

Cameron Cox, CEO of FutureLand Corp. said, "We always saw great value in Apotheca Biosciences. CBD and the benefits for the pharmacological community are far reaching and gaining ground every day.”

FutureLand Corp. (FUTL) purchased 20% of Apotheca Biosciences on Sept. 15, 2017 for a $100,000 note. Today the company announces that Apotheca Biosciences has been purchased by Cannabis Leaf (PCFP) through a merger agreement. FutureLand Corp. will receive 12,000,000 shares of newly issued (PCFP) common stock for its interest in Apotheca Biosciences.

With soaring market caps in the space, FutureLand Corp. is a big winner in the acquisition. It marks a turning point for the company’s fiscal health. FutureLand expects major growth for Cannabis Leaf via this transaction and plans on taking a long-term hold position in the company.

Apotheca Biosciences is developing cutting-edge medical products, nutraceuticals, formulation and delivery technologies for the healthcare and consumer care industry. They have a pipeline of products that include, transdermal, sublingual, and nasal delivery technologies for precise and controlled dosing of cannabinoids. We believe that they can deliver meaningful benefits using their technologies to the world’s aging population.

Further, Apotheca Biosciences is a pioneering biotech company with an emphasis in research and development in addition to the creation of high-grade nutraceuticals and cosmetics. The health of their customers takes precedence and their solid business strategy ensures their focus on customer well-being. Their goal is to lay the groundwork and continue research of cannabinoid receptiveness in patients and create nutraceuticals that reflects their research.

FutureLand Corp. is pleased with the investment and looks forward to great things to come from Apotheca Biosciences.

About FutureLand Corp.

FutureLand Corp., a Colorado company, is a cannabis and hemp specialty zoned land leasing company formed to capitalize upon the emerging global cannabis market. FutureLand, focuses on target acquisition, zoning, license fulfillment, site plan preparation and financing of cannabis or hemp grow facilities throughout the United States. We give growers the opportunity to grow. We monetize through leasing the land, leasing the structures on the land, financing interest revenue and management fees associated with cultivation centers. FutureLand retains ownership of all the land and the structures. FutureLand leases to both medical marijuana, retail marijuana as well as industrial hemp growers. FutureLand does not currently grow, distribute or sell marijuana. To request further information about FutureLand, please email us at [e-mail], log onto our website at https://www.futurelandcorp.com, or visit us on FB @ futurelandcorp and Twitter @futurelandcorp.

https://markets.businessinsider.com/news/stocks/futureland-corp-futl-realizes-arbitrage-on-apotheca-biosciences-acquisitionapotheca-biosciences-has-been-purchased-by-cannabis-leaf-inc-otc-pcfp-1018618804



. On Jan 20, 2015 FLP entered a contract with GPS, La Vita, Inc. allotting 5 acres for their immediate grow facilities. All of these contracts, and land ownings are currently in FLP.




Name: GPS La Vita, Inc, Delinquent June 1, 2016
ID number: 20151033950
Print-friendly version Print-friendly version
Found 7 matching record(s). Viewing page 1 of 1.
# Event Date Filed Date Posted EffectiveDate Click here to sort in ascending order. Document #
(click to view) Comment
1 Articles of Incorporation 01/17/2015 01/17/2015 01/17/2015 09:03 AM 20151033950
2 Periodic Report due 12/23/2015 12/23/2015 12/23/2015 02:36 AM Periodic report due by: 03/31/2016
3 Periodic Report due in one week 03/24/2016 03/24/2016 03/24/2016 02:21 AM Periodic report due by: 03/31/2016
4 Change in Status: Noncompliant for
failure to file Periodic Report 04/01/2016 04/01/2016 04/01/2016 01:38 AM Entity noncompliant and will become delinquent on: 05/31/2016
5 Change in status in one week:
Delinquent for failure to file
Periodic Report 05/24/2016 05/24/2016 05/24/2016 02:02 AM One week until delinquent: 05/31/2016
6 Change in Status: Delinquent for
failure to file Periodic Report 06/01/2016 06/01/2016 06/01/2016 01:41 AM Entity has become delinquent for failure to file Periodic Report
7 Change in Name 07/06/2017 07/06/2017 07/06/2017 12:43 AM Entity name and any active trade names changed due to Failure to file periodic report



https://www.sos.state.co.us/biz/BusinessEntityHistory.do?quitButtonDestination=BusinessEntityDetail&pi1=1&nameTyp=ENT&masterFileId=20151033950&entityId2=20151033950&srchTyp=ENTITY


FILING:

https://www.otcmarkets.com/filing/html?id=12927529&guid=MmYEUqZeHm-aWth